Have your own idea? Try our Stock Screener
Japanese (NIKKEI) Clinical Research and Equipment Industry Analysis
UpdatedMay 23, 2026
DataAggregated Company Financials
Companies13
- 7D2.6%
- 3M-19.0%
- 1Y-4.9%
- YTDn/a
Over the last 7 days, the Clinical Research and Equipment industry has risen 2.6%, driven by gains from Shin Nippon Biomedical Laboratories of 4.9%. In contrast, the industry has lost 4.9% in the last 12 months. Earnings are forecast to grow by 18% annually.
Industry Valuation and Performance
Has the Japanese Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 23 May 2026 | JP¥122.7b | JP¥62.9b | JP¥618.3m | 26.1x | 198.4x | 2x |
| Mon, 20 Apr 2026 | JP¥145.8b | JP¥63.3b | -JP¥864,496,000.00 | 22.9x | -168.6x | 2.3x |
| Wed, 18 Mar 2026 | JP¥144.3b | JP¥63.2b | -JP¥944,048,000.00 | 22.1x | -152.9x | 2.3x |
| Fri, 13 Feb 2026 | JP¥156.5b | JP¥63.4b | -JP¥593,693,000.00 | 24.9x | -263.6x | 2.5x |
| Sun, 11 Jan 2026 | JP¥153.3b | JP¥66.9b | JP¥72.2m | 21.7x | 2123.7x | 2.3x |
| Tue, 09 Dec 2025 | JP¥157.2b | JP¥67.6b | JP¥702.4m | 18x | 223.9x | 2.3x |
| Thu, 06 Nov 2025 | JP¥131.9b | JP¥66.5b | JP¥1.5b | 15.5x | 90.4x | 2x |
| Sat, 04 Oct 2025 | JP¥143.6b | JP¥66.5b | JP¥1.5b | 16.6x | 98.4x | 2.2x |
| Mon, 01 Sep 2025 | JP¥147.9b | JP¥66.5b | JP¥1.5b | 16.7x | 101.4x | 2.2x |
| Wed, 30 Jul 2025 | JP¥139.6b | JP¥66.0b | JP¥1.1b | 16.4x | 123.7x | 2.1x |
| Fri, 27 Jun 2025 | JP¥139.8b | JP¥66.0b | JP¥1.1b | 16.7x | 123.8x | 2.1x |
| Sun, 25 May 2025 | JP¥131.8b | JP¥66.0b | JP¥1.1b | 16.5x | 116.3x | 2x |
| Tue, 22 Apr 2025 | JP¥132.1b | JP¥63.8b | JP¥963.0m | 14.1x | 137.1x | 2.1x |
| Thu, 20 Mar 2025 | JP¥162.4b | JP¥64.8b | JP¥927.4m | 15.5x | 175.1x | 2.5x |
| Sat, 15 Feb 2025 | JP¥168.8b | JP¥65.3b | JP¥982.5m | 15.6x | 171.8x | 2.6x |
| Mon, 13 Jan 2025 | JP¥164.8b | JP¥62.0b | JP¥440.7m | 17.8x | 373.9x | 2.7x |
| Wed, 11 Dec 2024 | JP¥164.2b | JP¥62.0b | JP¥825.9m | 16.9x | 198.8x | 2.6x |
| Fri, 08 Nov 2024 | JP¥159.8b | JP¥61.5b | JP¥1.8b | 21.1x | 86.8x | 2.6x |
| Sun, 06 Oct 2024 | JP¥155.6b | JP¥61.5b | JP¥1.8b | 18.2x | 84.5x | 2.5x |
| Tue, 03 Sep 2024 | JP¥161.0b | JP¥61.5b | JP¥2.1b | 19.9x | 76.4x | 2.6x |
| Thu, 01 Aug 2024 | JP¥165.6b | JP¥61.8b | JP¥3.2b | 24.8x | 51.2x | 2.7x |
| Sat, 29 Jun 2024 | JP¥168.9b | JP¥61.8b | JP¥3.2b | 26.7x | 52.2x | 2.7x |
| Mon, 27 May 2024 | JP¥159.2b | JP¥61.8b | JP¥3.4b | 25x | 47.5x | 2.6x |
| Wed, 24 Apr 2024 | JP¥179.0b | JP¥62.3b | JP¥3.3b | 14.3x | 54.4x | 2.9x |
| Fri, 22 Mar 2024 | JP¥232.6b | JP¥155.4b | JP¥8.6b | 14x | 27x | 1.5x |
| Sun, 18 Feb 2024 | JP¥229.3b | JP¥155.3b | JP¥8.7b | 14.6x | 26.4x | 1.5x |
| Tue, 16 Jan 2024 | JP¥235.7b | JP¥167.1b | JP¥8.5b | 15.8x | 27.7x | 1.4x |
| Thu, 14 Dec 2023 | JP¥231.7b | JP¥167.4b | JP¥8.7b | 14.6x | 26.7x | 1.4x |
| Sat, 11 Nov 2023 | JP¥236.0b | JP¥168.0b | JP¥9.2b | 14.5x | 25.7x | 1.4x |
| Mon, 09 Oct 2023 | JP¥239.8b | JP¥179.3b | JP¥12.8b | 15.1x | 18.8x | 1.3x |
| Wed, 06 Sep 2023 | JP¥268.2b | JP¥179.3b | JP¥12.8b | 16.9x | 21x | 1.5x |
| Fri, 04 Aug 2023 | JP¥271.5b | JP¥179.8b | JP¥13.7b | 17.1x | 19.7x | 1.5x |
| Sun, 02 Jul 2023 | JP¥282.6b | JP¥178.5b | JP¥16.2b | 17.5x | 17.4x | 1.6x |
| Tue, 30 May 2023 | JP¥283.4b | JP¥178.2b | JP¥15.9b | 16.6x | 17.8x | 1.6x |
Price to Earnings Ratio
17.8x
Current Industry PE
- Investors are optimistic on the Japanese Life Sciences Tools and Services industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 198x which is higher than its 3-year average PE of 170x.
- The industry is trading close to its 3-year average PS ratio of 2.1x.
Past Earnings Growth
- The earnings for companies in the Life Sciences Tools and Services industry have declined 66% per year over the last three years,
- Revenues have also declined 29% per year.
- This means overall sales from these companies are declining and profits are subsequently falling as well.
Industry Comparison
How does Japanese Clinical Research and Equipment compare with similar industries?
| JP Market | 1.18% | |
| Healthcare | 0.53% | |
| Life Sciences | 2.58% | |
| Clinical Research and Equipment | 2.58% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 2395 Shin Nippon Biomedical Laboratories | JP¥1.28k | 4.9% +JP¥2.5b | 0.8% | PE11.7x | |
| 7707 Precision System Science | JP¥277.00 | 14.0% +JP¥933.7m | 35.8% | PE56.8x | |
| 4583 Chiome Bioscience | JP¥97.00 | 5.4% +JP¥363.2m | -30.2% | PS11.9x | |
| 6090 Human Metabolome Technologies | JP¥656.00 | 4.8% +JP¥168.8m | -14.6% | PE31.6x | |
| 4572 Carna Biosciences | JP¥453.00 | 1.3% +JP¥115.1m | 61.2% | PS14x |